Table 3.
Patient characteristics according to IDH mutation split by grade. No differences were found between patients with IDHmut and IDHwt tumors in terms of localization, stage at diagnosis, morphology, and Syndrome coexistence
| G2 (N = 41) | G3 (N = 13) | |||||||
|---|---|---|---|---|---|---|---|---|
|
IDHmut N = 15 (37%) |
IDHwt N = 26 (63%) |
All G2 |
P value |
IDHmut N = 9 (69%) |
IDHwt N = 4 (31%) |
All G3 |
P value |
|
| Site, n (%) | ||||||||
| Extremity | 10 (67) | 10 (38) | 20 | 0.23 | 4 (44) | 1 (25) | 5 | 0.44 |
| Pelvis | 3 (20) | 10 (38) | 13 | 4 (44) | 1 (25) | 5 | ||
| Other | 2 (13) | 6 (24) | 8 | 1 (12) | 2 (50) | 3 | ||
| Stage, n (%) | ||||||||
| Localized | 12 (80) | 21 (81) | 33 | 1.0 | 5 (56) | 2 (50) | 7 | 1.0 |
| Metastatic | 3 (20) | 5 (19) | 8 | 4 (44) | 2 (50) | 6 | ||
| Margins, n (%) | ||||||||
| Wide | 10 (67) | 20 (83) | 30 | 0.27 | 7 (78) | 2 (50) | 9 | 0.53 |
| Not-wide | 5 (33) | 4 (17) | 9 | 2 (22) | 2 (50) | 4 | ||
| Uk | 2 | 2 | ||||||